A detailed history of First Trust Advisors LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 47,599 shares of HRMY stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,599
Previous 69,422 31.44%
Holding current value
$1.62 Million
Previous $2.09 Million 9.22%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.0 - $39.95 $654,690 - $871,828
-21,823 Reduced 31.44%
47,599 $1.9 Million
Q2 2024

Aug 13, 2024

BUY
$28.81 - $33.01 $1.65 Million - $1.89 Million
57,327 Added 473.97%
69,422 $2.09 Million
Q1 2024

May 13, 2024

SELL
$29.93 - $35.06 $692,939 - $811,709
-23,152 Reduced 65.69%
12,095 $406,000
Q4 2023

Feb 13, 2024

BUY
$19.2 - $33.78 $475,833 - $837,169
24,783 Added 236.84%
35,247 $1.14 Million
Q3 2023

Nov 13, 2023

BUY
$31.89 - $39.03 $333,696 - $408,409
10,464 New
10,464 $342,000
Q1 2023

May 15, 2023

SELL
$30.8 - $53.92 $3.62 Million - $6.34 Million
-117,579 Reduced 57.71%
86,174 $2.81 Million
Q4 2022

Feb 09, 2023

BUY
$45.4 - $60.91 $587,203 - $787,809
12,934 Added 6.78%
203,753 $11.2 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $941,050 - $1.24 Million
22,374 Added 13.28%
190,819 $8.45 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $202,749 - $315,246
6,045 Added 3.72%
168,445 $8.22 Million
Q1 2022

May 13, 2022

BUY
$33.14 - $51.13 $1.58 Million - $2.44 Million
47,775 Added 41.68%
162,400 $7.9 Million
Q4 2021

Feb 08, 2022

BUY
$34.09 - $43.91 $3.91 Million - $5.03 Million
114,625 New
114,625 $4.89 Million
Q4 2020

Feb 02, 2021

SELL
$31.74 - $51.34 $1.94 Million - $3.13 Million
-61,030 Closed
0 $0
Q3 2020

Nov 05, 2020

BUY
$30.96 - $44.39 $1.89 Million - $2.71 Million
61,030 New
61,030 $2.07 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.